Anonymous
Shares of AstraZeneca fell 8per cent early on Monday, hit by doubts about the British firm's strategy and speculation of a rival bid after it announced the US$39 billion purchase of Alexion Pharmaceuticals over the weekend.
2
Discussion (2)
Learn how to style your text
Reply
Save
Write your thoughts
Related Articles
Related Posts
Related Posts
Why do you want to buy this stock? I rather focus on recovery stocks like trip.com